标题
Sulindac metabolites decrease cerebrovascular malformations inCCM3-knockout mice
作者
关键词
-
出版物
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 112, Issue 27, Pages 8421-8426
出版商
Proceedings of the National Academy of Sciences
发表日期
2015-06-25
DOI
10.1073/pnas.1501352112
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Exceptional aggressiveness of cerebral cavernous malformation disease associated with PDCD10 mutations
- (2014) Robert Shenkar et al. GENETICS IN MEDICINE
- KRIT1 Protein Depletion Modifies Endothelial Cell Behavior via Increased Vascular Endothelial Growth Factor (VEGF) Signaling
- (2014) Peter V. DiStefano et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- NSAIDs Inhibit Tumorigenesis, but How?
- (2013) Evrim Gurpinar et al. CLINICAL CANCER RESEARCH
- Sulindac Selectively Inhibits Colon Tumor Cell Growth by Activating the cGMP/PKG Pathway to Suppress Wnt/ -Catenin Signaling
- (2013) N. Li et al. MOLECULAR CANCER THERAPEUTICS
- EndMT contributes to the onset and progression of cerebral cavernous malformations
- (2013) Luigi Maddaluno et al. NATURE
- COX-Independent Mechanisms of Cancer Chemoprevention by Anti-Inflammatory Drugs
- (2013) Evrim Gurpinar et al. Frontiers in Oncology
- Wnt/β-Catenin Signaling and Disease
- (2012) Hans Clevers et al. CELL
- Critical Reevaluation of Endothelial Progenitor Cell Phenotypes for Therapeutic and Diagnostic Use
- (2012) Gian Paolo Fadini et al. CIRCULATION RESEARCH
- Endothelial–mesenchymal transition and its contribution to the emergence of stem cell phenotype
- (2012) Damian Medici et al. SEMINARS IN CANCER BIOLOGY
- Wnt Signaling in Cancer
- (2012) P. Polakis Cold Spring Harbor Perspectives in Biology
- Targeting the Wingless Signaling Pathway with Natural Compounds as Chemopreventive or Chemotherapeutic Agents
- (2011) Marie-Helene Teiten et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Developmental timing of CCM2 loss influences cerebral cavernous malformations in mice
- (2011) Gwénola Boulday et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Fasudil Decreases Lesion Burden in a Murine Model of Cerebral Cavernous Malformation Disease
- (2011) David A. McDonald et al. STROKE
- The Wnt/β-Catenin Pathway Modulates Vascular Remodeling and Specification by Upregulating Dll4/Notch Signaling
- (2010) Monica Corada et al. DEVELOPMENTAL CELL
- CCM1 regulates vascular-lumen organization by inducing endothelial polarity
- (2010) M. G. Lampugnani et al. JOURNAL OF CELL SCIENCE
- Stabilization of VEGFR2 Signaling by Cerebral Cavernous Malformation 3 Is Critical for Vascular Development
- (2010) Y. He et al. Science Signaling
- Evaluating Strategies for the Treatment of Cerebral Cavernous Malformations
- (2010) D. Y. Li et al. STROKE
- Rap1 and its effector KRIT1/CCM1 regulate -catenin signaling
- (2009) A. J. Glading et al. Disease Models & Mechanisms
- Wnt/ -catenin signaling is required for CNS, but not non-CNS, angiogenesis
- (2009) R. Daneman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Wnt/β-catenin signaling controls development of the blood–brain barrier
- (2008) Stefan Liebner et al. JOURNAL OF CELL BIOLOGY
- Endothelial adherens junctions control tight junctions by VE-cadherin-mediated upregulation of claudin-5
- (2008) Andrea Taddei et al. NATURE CELL BIOLOGY
- Canonical Wnt Signaling Regulates Organ-Specific Assembly and Differentiation of CNS Vasculature
- (2008) J. M. Stenman et al. SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started